Home Clinical Topics Cardio-Pulmonary

Cardio-Pulmonary

Promoting safe use of parenteral anticoagulants

Nurses can take the lead in preventing harm related to heparin administration. Takeaways Parenteral anticoagulants require appropriate patient teaching to enhance adherence to medication administration. ...

Cardiogenic pulmonary edema

Takeaways Cardiogenic pulmonary edema can occur secondary to acute decompensated heart failure. Treatment should focus on reducing preload and afterload. Albert Jones*, age 65, is...

Outpatient care of patients with COPD

Controlling symptoms and preventing exacerbations are the key to patient quality of life. Takeaways: Nurses must be able to identify patients with chronic obstructive pulmonary...

A team approach to STEMI treatment protocols

A community hospital’s initiative improves patient outcomes. Takeaways: Few practice guidelines focus on in-hospital ST-elevation myocardial infarctions (STEMIs). Challenges related to inpatient STEMIs include delays...

Managing carotid stenosis to prevent stroke

Watch for warning signs to reduce risk. Takeaways: Approximately 87% of all strokes are ischemic, with 30% directly attributed to atherosclerosis of the internal carotid...

Study reveals no link between statin use and cognitive decline

A new study offers insight into a question that’s plagued healthcare for some time: Does an association exist between statin use and cognitive decline? A...

New research in the prevention of venous thromboembolism

By American Nurse Today Editorial Staff Research Objective A recent study examines the use of intermittent pneumatic compression (IPC) to prevent venous thromboembolism (VTE) in patients who are...

Central vascular access device complications:

The nurse’s role at each point of care Takeaways: Central vascular access devices (CVADs) can be essential to accomplishing patient therapeutic regimens. Nurses must be...

Atypical presentation of myocardial infarction

Quickly recognizing unusual symptoms can save lives. Takeaways  Cardiovascular disease remains the leading cause of death in women, but it’s often under-recognized because of atypical...

FDA approves treatment for two rare diseases

On May 6, the FDA approved Ruzurgi (amifampridine) tablets for the treatment of Lambert-Eaton myasthenic syndrome in patients 6 to less than 17 years...